GLOW trial: Is fixed duration ibrutinib + venetoclax a feasible frontline treatment option for CLL? Lymphoma Hub 6:15 3 years ago 176 Далее Скачать
Outcomes in high-risk CLL patients following fixed-duration treatment with ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 2:43 1 year ago 621 Далее Скачать
CLL14: feasibility of fixed-duration frontline therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:32 2 years ago 164 Далее Скачать
Fixed-duration treatment strategies for frontline and relapsed CLL VJHemOnc – Video Journal of Hematology & HemOnc 0:56 1 year ago 172 Далее Скачать
GLOW: Assessing ibrutinib plus venetoclax in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:54 2 years ago 364 Далее Скачать
Dr. Smith on the Rationale Behind the Fixed Duration Trial for Ibrutinib/Venetoclax in CLL OncLive 1:31 5 years ago 314 Далее Скачать
MRD outcomes from GLOW: venetoclax and ibrutinib in CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:09 3 years ago 188 Далее Скачать
Ibrutinib Plus Venetoclax as a Treatment Option for CLL Targeted Oncology 1:07 5 years ago 822 Далее Скачать
Fixed-duration ibrutinib and venetoclax for first-line CLL ecancer 7:36 3 years ago 123 Далее Скачать
CAPTIVATE: fixed-duration ibrutinib plus venetoclax in patients with CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 1:23 3 years ago 175 Далее Скачать
The future of fixed-duration therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:56 2 years ago 127 Далее Скачать
CAPTIVATE: Fixed-duration first-line treatment with ibrutinib plus venetoclax for CLL/SLL ecancer 11:23 3 years ago 92 Далее Скачать
Frontline ibrutinib + venetoclax in CLL: Results from a fixed duration cohort of the CAPTIVATE study Lymphoma Hub 4:45 3 years ago 108 Далее Скачать
Six-year update from CLL14: fixed-duration venetoclax + obinutuzumab for previously untreated CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:43 1 year ago 298 Далее Скачать
Update on fixed-duration cohort of CAPTIVATE trial for CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 2:27 3 years ago 216 Далее Скачать
Phase III GLOW trial: Ibrutinib plus venetoclax in previously untreated CLL/SLL Lymphoma Hub 25:06 4 months ago 148 Далее Скачать
Ibrutinib + venetoclax for first-line treatment of chronic lymphocytic leukaemia (CLL)/small lym... ecancer 6:47 2 years ago 90 Далее Скачать
Front-line treatment options for CLL | Dr. Jeff Sharman | Oncology Brothers #2023 OncBrothers: Practice-Changing Cancer Discussions 0:49 1 year ago 667 Далее Скачать
CAPTIVATE: Ibrutinib and venetoclax in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:21 2 years ago 371 Далее Скачать
GLOW: primary analysis of ibrutinib plus venetoclax versus obinutuzumab plus chlorambucil in CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:34 3 years ago 206 Далее Скачать
